Medicines for type 2 diabetes

Medicines (by active ingredient)

AtorvastatinAdults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in. MetforminMetformin hydrochloride extended-release tablets are a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in. LosartanTreatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension. GlimepirideGlimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in. EmpagliflozinAdults with type 2 diabetes mellitus and established cardiovascular disease. SitagliptinJANUVIA ® is indicated as an adjunct to diet and exercise to improve glycemic control in. IrbesartanTreatment of diabetic nephropathy in hypertensive patients with type 2 diabetes, an elevated serum creatinine, and proteinuria. Insulin GlargineBASAGLAR ® is indicated to improve glycemic control in. LinagliptinTRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in. GlipizideGlipizide Tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in. Insulin DegludecTRESIBA is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus. Insulin LisproADMELOG is indicated to improve glycemic control in. FenofibrateLimitations of Use: Fenofibrate was not shown to reduce coronary heart disease morbidity and mortality in patients with type 2 diabetes mellitus. SaxagliptinSaxagliptin tablets are a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in. Insulin GlulisineAPIDRA is indicated to improve glycemic control in. MifepristoneAdult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. LiraglutideLiraglutide injection is indicated: as an adjunct to diet and exercise to improve glycemic control in. GlucagonAdult patients with diabetes mellitus. Insulin HumanAFREZZA ® is indicated to improve glycemic control in. Insulin AspartNOVOLOG is indicated to improve glycemic control in. Insulin Aspart ProtamineInsulin Aspart Protamine and Insulin Aspart Mix 70/30 is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in.

Brands

GlibenclamideGlyburide tablets, USP is indicated as an adjunct to diet and exercise to improve glycemic control in. PioglitazoneMonotherapy and Combination Therapy Pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in. GlyburideGlyburide tablets, USP is indicated as an adjunct to diet and exercise to improve glycemic control in. DapagliflozinAdults with type 2 diabetes mellitus and either established CV disease or multiple CV risk factors. TicagrelorWhile use is not limited to this setting, the efficacy of ticagrelor was established in a population with type 2 diabetes mellitus (T2DM). RepaglinideRepaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in. Insulin Lispro ProtamineInsulin Lispro Protamine and Insulin Lispro Mix75/25 is indicated to improve glycemic control in.